Overview

This trial is active, not recruiting.

Conditions rare peritoneal surface malignancies, pseudomyxoma peritonei, peritoneal mesothelioma, desmoplastic small round cell tumor, psammocarcinoma, primary peritoneal serous carcinoma, diffuse peritoneal leiomyomatosis, appendiceal mucinous neoplasms
Treatment non interventional
Sponsor Hospices Civils de Lyon
Start date October 2010
End date December 2018
Trial size 2171 participants
Trial identifier NCT02834169, 69HCL16_0406

Summary

Despite advances in the management of and changes in clinical practice, little is known about the epidemiology, patterns of care and outcomes of rare peritoneal surface malignancies patients in France.

In order to better understand the characteristics of rare peritoneal surface malignancies and to evaluate treatment strategies, the RENAPE registry aims at the collection of data from patients presenting with a rare peritoneal surface malignancy in France. Data will be entered prospectively in a specifically designed and secured web database.

All RENAPE's centres and physicians are invited to register patients with a rare peritoneal surface malignancy diagnosis and to participate to the registry. Data will be evaluated within regular time frames, focusing on types of rare peritoneal surface malignancies, treatment modalities and patient outcomes (e.g. survival, recurrence), thereby contributing to the better understanding of these rare cancers.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Arm
Data from pseudomyxoma peritonei cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
non interventional
Data collection
Data from peritoneal mesothelioma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
non interventional
Data collection
Data from desmoplastic small round cell tumor cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
non interventional
Data collection
Data from primary peritoneal serous carcinoma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
non interventional
Data collection
Data from primary peritoneal serous carcinoma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
non interventional
Data collection
Data from diffuse peritoneal leiomyomatosis cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
non interventional
Data collection
Data from appendiceal mucinous neoplasms cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
non interventional
Data collection

Primary Outcomes

Measure
Incidence of rare peritoneal surface malignancies
time frame: year 5

Secondary Outcomes

Measure
Impact of specific treatment strategies
time frame: year 5

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Patients are eligible if they have a histologically proven rare peritoneal surface malignancy. Exclusion Criteria: - Histological diagnostic of peritoneal surface malignancy not confirmed - Expected clinical follow up data not available

Additional Information

Official title French National Registry of Rare Peritoneal Surface Malignancies (RENAPE Registry)
Principal investigator François-Noël GILLY, Prof
Trial information was received from ClinicalTrials.gov and was last updated in July 2016.
Information provided to ClinicalTrials.gov by Hospices Civils de Lyon.